↓ Skip to main content

Dove Medical Press

Article Metrics

Role of CD44 as a marker of cancer stem cells in head and neck cancer

Overview of attention for article published in Biologics: Targets & Therapy, November 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
49 Mendeley
Title
Role of CD44 as a marker of cancer stem cells in head and neck cancer
Published in
Biologics: Targets & Therapy, November 2012
DOI 10.2147/btt.s37906
Pubmed ID
Authors

Eugenia Allegra, Trapasso

Abstract

In recent years, many studies have shown that some types of tumors are characterized by the presence of cells with stem-like characteristics, called cancer stem cells (CSCs). These are considered cells that initiate the tumor and are probably responsible for tumor recurrence. CSCs have the capacity for self-renewal, the potential to give rise to one or more cell types within the tumor, and the ability to drive, in a continuous manner, the proliferation of malignant cells. The failure of current cancer therapies can be attributed to the relative ineffectiveness of drugs against CSCs, which remain viable while retaining their full ability to reproduce the tumor. The development of new strategies is currently hampered by the lack of reliable markers to identify CSCs. One promising surface marker of CSCs in head and neck cancer is the CD44 molecule, which has been shown in preliminary studies to have high specificity, although there are discrepant data because its prognostic value may depend on the specific tumor location. More rigorous studies are needed to investigate the usefulness of CD44 expression in head and neck tumors for possible clinical applicability.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 29%
Researcher 8 16%
Other 6 12%
Student > Bachelor 5 10%
Student > Master 4 8%
Other 9 18%
Unknown 3 6%
Readers by discipline Count As %
Medicine and Dentistry 19 39%
Agricultural and Biological Sciences 11 22%
Biochemistry, Genetics and Molecular Biology 9 18%
Economics, Econometrics and Finance 1 2%
Social Sciences 1 2%
Other 3 6%
Unknown 5 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2012.
All research outputs
#3,554,232
of 4,507,280 outputs
Outputs from Biologics: Targets & Therapy
#86
of 114 outputs
Outputs of similar age
#65,458
of 82,417 outputs
Outputs of similar age from Biologics: Targets & Therapy
#5
of 7 outputs
Altmetric has tracked 4,507,280 research outputs across all sources so far. This one is in the 3rd percentile – i.e., 3% of other outputs scored the same or lower than it.
So far Altmetric has tracked 114 research outputs from this source. They receive a mean Attention Score of 2.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,417 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.